Frösler, H.M.; Mancapa, N.R.; Catenacci, L.; Sorrenti, M.; Bonferoni, M.C.; Caira, M.R.
Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. Pharmaceutics 2025, 17, 842.
https://doi.org/10.3390/pharmaceutics17070842
AMA Style
Frösler HM, Mancapa NR, Catenacci L, Sorrenti M, Bonferoni MC, Caira MR.
Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. Pharmaceutics. 2025; 17(7):842.
https://doi.org/10.3390/pharmaceutics17070842
Chicago/Turabian Style
Frösler, Hannah M., Neo Refiloe Mancapa, Laura Catenacci, Milena Sorrenti, Maria Cristina Bonferoni, and Mino R. Caira.
2025. "Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer" Pharmaceutics 17, no. 7: 842.
https://doi.org/10.3390/pharmaceutics17070842
APA Style
Frösler, H. M., Mancapa, N. R., Catenacci, L., Sorrenti, M., Bonferoni, M. C., & Caira, M. R.
(2025). Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. Pharmaceutics, 17(7), 842.
https://doi.org/10.3390/pharmaceutics17070842
